Suppr超能文献

儿童肾移植后癌症的发生率及预测因素。

Incidence and Predictors of Cancer Following Kidney Transplantation in Childhood.

机构信息

Sydney School of Public Health, University of Sydney, Camperdown, NSW, Australia.

Centre for Kidney Research, Kids Research Institute at The Children's Hospital at Westmead, Westmead, NSW, Australia.

出版信息

Am J Transplant. 2017 Oct;17(10):2650-2658. doi: 10.1111/ajt.14289. Epub 2017 May 8.

Abstract

Cancer risk is increased substantially in adult kidney transplant recipients, but the long-term risk of cancer in childhood recipients is unclear. Using the Australian and New Zealand Dialysis and Transplant Registry, the authors compared overall and site-specific incidences of cancer after transplantation in childhood recipients with population-based data by using standardized incidence ratios (SIRs). Among 1734 childhood recipients (median age 14 years, 57% male, 85% white), 289 (16.7%) developed cancer (196 nonmelanoma skin cancers, 143 nonskin cancers) over a median follow-up of 13.4 years. The 25-year cumulative incidences of any cancer were 27% (95% confidence intervals 24-30%), 20% (17-23%) for nonmelanoma skin cancer, and 14% (12-17%) for nonskin cancer (including melanoma). The SIR for nonskin cancer was 8.23 (95% CI 6.92-9.73), with the highest risk for posttransplant lymphoproliferative disease (SIR 45.80, 95% CI 32.71-62.44) and cervical cancer (29.4, 95% CI 17.5-46.5). Increasing age at transplantation (adjusted hazard ratio [aHR] per year 1.10, 95% CI 1.06-1.14), white race (aHR 3.36, 95% CI 1.61-6.79), and having a functioning transplant (aHR 2.27, 95% CI 1.47-3.71) were risk factors for cancer. Cancer risk, particularly for virus-related cancers, is increased substantially after kidney transplantation during childhood.

摘要

儿童肾移植受者的癌症风险显著增加,但儿童受者癌症的长期风险尚不清楚。作者利用澳大利亚和新西兰透析和移植登记处,使用标准化发病比(SIR)将儿童受者移植后的总体和特定部位癌症发病率与基于人群的数据进行了比较。在 1734 名儿童受者(中位年龄 14 岁,57%为男性,85%为白人)中,中位随访 13.4 年后有 289 名(196 例非黑色素瘤皮肤癌,143 例非皮肤癌)发生癌症。任何癌症的 25 年累积发生率为 27%(95%置信区间 24%-30%)、20%(17%-23%)为非黑色素瘤皮肤癌,14%(12%-17%)为非皮肤癌(包括黑色素瘤)。非皮肤癌的 SIR 为 8.23(95%CI 6.92-9.73),其中移植后淋巴增生性疾病(SIR 45.80,95%CI 32.71-62.44)和宫颈癌(29.4,95%CI 17.5-46.5)风险最高。移植时年龄增加(调整后的风险比[HR]每年增加 1.10,95%CI 1.06-1.14)、白种人(HR 3.36,95%CI 1.61-6.79)和有功能的移植(HR 2.27,95%CI 1.47-3.71)是癌症的危险因素。儿童期肾移植后,癌症风险显著增加,特别是与病毒相关的癌症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验